Activated protein C protection from lung inflammation in endotoxin-induced injury

Experimental Biology and Medicine

Volumn 233, Issue 11, 2008, Pages 1462-1468

  Pirrone, Federica ^a   Mazzola, Silvia M ^a   Pastore, Camilla ^a   Paltrinieri, Saverio ^a   Sironi, Giuseppe ^a   Riccaboni, Pietro ^a   Viola, Manuela ^b   Passi, Alberto ^b   Clement, Maria G ^a   Albertini, Mariangela ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Activated protein C; Acute lung injury; Matrix metalloproteinases; Sepsis; Swine

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; DROTRECOGIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; PROTECTIVE AGENT; PROTEIN C; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING MECHANICS; CELL COUNT; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ESCHERICHIA COLI; FEMALE; HISTOLOGY; LUNG COMPLIANCE; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; MALE; NEUTROPHIL; NONHUMAN; PNEUMONIA; RESPIRATORY FUNCTION; SWINE; ZYMOGRAPHY; ANIMAL; CHEMISTRY; CYTOLOGY; HUMAN; LUNG FUNCTION TEST; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ANIMALIA; ESCHERICHIA COLI; PIERIS BRASSICAE; SUIDAE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; ESCHERICHIA COLI; HUMANS; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASES; PNEUMONIA; PROTECTIVE AGENTS; PROTEIN C; RECOMBINANT PROTEINS; RESPIRATORY FUNCTION TESTS; SWINE;

EID: 58249083923     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0802-RM-74     Document Type: Article

References (26)

1. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 29:S109-S116, 2001.
2. Esmon CT. The endothelial protein C receptor. Thromb Haemost 83: 639-643, 2000.
3. Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 120:915-922, 2001.
4. Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood 101:20-30, 2003.
5. Nicolaes GAF, Dahlback B. Factor V and thrombotic disease: description of a Janus-faced protein. Arterioscler Thromb Vasc Biol 22:530-538, 2002.
6. Joyce DE, Grinnell BW. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappa B. Crit Care Med 30:S288-S293, 2002.
7. Gushima Y, Ichikado K, Suga M, Okamoto T, Iyonaga K, Sato K, Miyakawa H, Ando M. Expression of matrix metalloproteinases in pigs with hyperoxia-induced acute lung injury. Eur Respir J 18:827-837, 2001.
8. Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM, Dayer JM. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 154:346-352, 1996.
9. Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 14:288-293, 1996.
10. Lanchou J, Corbel M, Boichot E, Germain N, Tanguy M, Theret N, Clement B, Malledant Y, Lagente V. Imbalance between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in the bronchoalveolar lavage of patients with long-lasting ARDS. Eur Respir J S31:374S, 2000.
11. D'Ortho MP, Jarreau PH, Delacourt C, Macquinmavier I, Levame M, Pezet S, Harf A, Lafuma C. Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs. Am J Physiol 266:L209-L216, 1994.
12. Gibbs DF, Shanley TP, Warner RL, Murphy HS, Varani J, Johnson KJ. Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Evidence for alveolar macrophage as source of proteinases. Am J Respir Cell Mol Biol 20:1145-1154, 1999.
13. Kim JH, Suk M, Yoon DW, Lee SH, Hur GY, Jung KH, Jeong HC, Lee SY, Suh IB, Shin C, Shim JJ, In KH, Yoo SH, Kang KH. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 291:L580-L587, 2006.
14. Mazzola S, Forni M, Albertini M, Bacci ML, Zannoni A, Gentilini F, Lavitrano M, Bach FH, Otterbein LE, Clement MG. Carbon monoxide pretreatment prevents respiratory derangement and ameliorates hyper- acute endotoxic shock in pigs. FASEB J 19:2045-2047, 2005.
15. Vigetti D, Moretto P, Viola M, Genasetti A, Rizzi M, Karousou E, Pallotti F, De Luca G, Passi A. Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging. FASEB J 20:1118-1130, 2006.
16. Souza-Costa DC, Zerbini T, Palei AC, Gerlach RF, Tanus-Santos JE. L- Arginine attenuates acute pulmonary embolism-induced increase in lung matrix metalloproteinase-2 and matrix metalloproteinase-9. Chest 128:3705-3710, 2005.
17. Ferry G, Lonchampt M, Pennel L, de Nanteuil G, Canet E, Tucker GC. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett 402:111-115, 1997.
18. Pardo A, Selman M, Ridge K, Barrios R, Sznajder JI. Increased expression of gelatinases and collagenase in rat lungs exposed to 100% oxygen. Am J Respir Crit Care Med 154:1067-1075, 1996.
19. Negrini D, Tenstad O, Passi A, Wiig H. Differential degradation of matrix proteoglycans and edema development in rabbit. Am J Physiol Lung Cell Mol Physiol 290:L470-L477, 2006.
20. Negrini D, Moriondo A, Pelosi P, Severgnini P, Passi A, Viola M, Ottani V, Quaranta M. Metalloproteinase activation in spontaneously breathing or mechanically ventilated healthy rabbits (abstract). American Physiological Society/International Union of Physiological Sciences Meeting, March 31-April 5, 2005, San Diego, CA.
21. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. Matrix metalloproteinase processing of monocyte chemo- attractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100:1160-1167, 2002.
22. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87:642-647, 1996.
23. Robriquet L, Collet F, Tournoys A, Prangère T, Nevière R, Fourier F, Guery BP. Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response. Respir Res 7:41, 2006.
24. Looney MR, Matthay MA. Bench-to-bedside review: the role of activated protein C in maintaining endothelial tight junction function and its relationship to organ injury. Crit Care 10:239, 2006.
25. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, Richter D, Kast RK, Abraham E. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104:3878-3885, 2004.
26. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez- Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709, 2001.